Evidence map›Paper›PMID 41832291›Full record

ArticleScientific reports2026

Repetitive after-discharges are more common in acquired demyelinating polyneuropathies.

Handan Uzunçakmak-Uyanık, Fatma Gökçem Yıldız, Çağrı Mesut Temuçin

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Handan Uzunçakmak-UyanıkInstitute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey. h_uzuncakmak@hotmail.com.
Fatma Gökçem YıldızDepartment of Neurology, School of Medicine, Hacettepe University, Ankara, Turkey.
Çağrı Mesut TemuçinDepartment of Neurology, School of Medicine, Hacettepe University, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repetitive after-discharges (RAD) following compound muscle action potential (CMAP) have been increasingly observed during F-wave studies in the diagnosis of demyelinating polyneuropathy. RAD was defined as repetitive potentials occurring within 500 ms after the initial CMAP at 1 mV/div sensitivity. EMG traces from patients with demyelinating polyneuropathy (n = 91), sensorimotor axonal polyneuropathy (n = 119) and normal subjects (n = 84) were reviewed to identify RAD during F-wave studies. The temporal relationship between RAD and the mixed nerve silent period (MNSP) was also assessed. RAD was detected in 90.1% of patients with demyelinating polyneuropathy, 29.4% of patients with sensorimotor axonal polyneuropathy, and 2.3% of normal subjects. Among patients with hereditary demyelinating polyneuropathy, RAD was present in 19.4%. In 84.7% of traces with obtainable F-waves, the initial RAD components appeared during the first period of MNSP. RAD may serve as a useful electrophysiological indicator of demyelinating polyneuropathy and may help distinguish it from sensorimotor axonal polyneuropathy and healthy individuals. It may also contribute to differentiating hereditary from acquired demyelinating polyneuropathies. The occurrence of RAD during the first period of MNSP, when voluntary motor activity is suppressed, suggests that these signals are not due to incomplete relaxation or voluntary discharges.

Indexed as

Action PotentialsDemyelinating DiseasesPolyneuropathiesAdultAgedElectromyographyFemaleHumansMaleMiddle AgedNerve Conduction StudiesNeural ConductionDemyelinating polyneuropathyEphaptic-ectopicF-waveMixed nerve silent periodRepetitive after-discharges

Identifiers

PMID41832291
PMCPMC13036086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.